CRRT machine market seen reaching $2.07 billion by 2030

The continuous renal replacement therapy machine market is projected to grow from $1.37 billion in 2025 to $1.49 billion in 2026, driven by rising acute kidney injury cases, ICU admissions and demand for gentler renal support. The Business Research Company expects the market to reach $2.07 billion by 2030, with North America leading now and Asia-Pacific set for the fastest growth.

Why it matters: - Continuous renal replacement therapy machines help treat critically ill patients with acute kidney injury and fluid overload in intensive care units. - Rising demand reflects broader pressure on critical care systems, especially as kidney complications and ICU admissions increase worldwide. - The market outlook points to continued investment in advanced renal care tools, especially in regions expanding critical care capacity.

What happened: - The Business Research Company released a report on the global continuous renal replacement therapy machine market on Aug. 1, 2026. - The market is estimated to grow from $1.37 billion in 2025 to $1.49 billion in 2026. - The report projects the market will reach $2.07 billion by 2030. - The report includes a free sample here and the full report here.

The details: - The report estimates an 8.7% compound annual growth rate for 2025 to 2026. - It forecasts an 8.6% CAGR through 2030. - Key historical growth drivers include more acute kidney injury cases in ICUs, higher rates of sepsis and multi-organ failure, expanding critical care infrastructure, wider adoption of continuous renal support therapies, and improved survival among critically ill patients. - Key future drivers include aging populations, more demand for gentle renal replacement therapies, rising ICU admissions, personalized critical care, and advanced critical care facilities in emerging economies. - The report highlights growing use of CRRT machines in ICUs. - The report points to greater demand for continuous dialysis in hemodynamically unstable patients. - The report identifies growth in mobile and portable CRRT units. - The report also flags expanding use in pediatric and geriatric care. - The report emphasizes more precise fluid and solute management. - CRRT machines provide continuous dialysis over 24 hours and are designed for patients who cannot tolerate intermittent dialysis. - These machines remove waste and excess fluid more gradually, reducing hemodynamic stress. - The machines substitute for kidney filtration when renal function is compromised by sudden injury or illness. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The regional analysis also covers Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The growth story is tied less to one product upgrade and more to the broader rise in critical care complexity. - Portable and precision-focused CRRT systems suggest buyers want more flexibility at the bedside and tighter fluid control. - Asia-Pacific’s expected growth likely reflects infrastructure buildout and rising awareness of renal disease, while North America remains the most established market.

What's next: - The market’s path will likely depend on ICU volumes, AKI prevalence and how quickly hospitals in emerging markets add advanced renal care capability. - Product development is likely to keep shifting toward portability, pediatric and geriatric use, and more precise treatment control. - The report encourages interested readers to speak with the company’s expert contacts listed in the release.